David Foster has been named vice president of finance andchief financial officer at Collagen Corp. He will continue tomanage the Palo Alto, Calif., company's (NASDAQ:CGEN) MISgroup and perform accounting and investor relations functions.Collagen develops, manufactures and markets biomedicaldevices for the treatment of defective, diseased, traumatized oraging human tissues.

Marc C. Ostro, co-founder of The Liposome Company, wasappointed to the board at VimRx Pharmaceuticals Inc. ofStamford, Conn. He recently resigned from Liposome to head anew biotech investment firm. VimRx (NASDAQ:VMRX) isdeveloping therapies to fight the spread of viral and retroviraldiseases.

(c) 1997 American Health Consultants. All rights reserved.